Publications by authors named "Dave Cervi"

Claim this Profile
O
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity.
Yuval Shaked, Urban Emmenegger, Shan Man, Dave Cervi, Francesco Bertolini

Blood· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells.
Yuval Shaked, Dave Cervi, Manuela Neuman, Limor Chen, Giannoula Klement

Blood· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
Yuval Shaked, Francesco Bertolini, Shan Man, Michael S Rogers, Dave Cervi

Cancer Cell· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.
Dave Cervi, Giannoula Klement, Diana Stempak, Sylvain Baruchel, Alane Koki

Clin Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.
Christina R Lee, Dave Cervi, Amandine H Truong, You-Jun Li, Aloke Sarkar

Anticancer Res· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis